Alan Goldberg, MD
Family Medicine · Pottstown, PANPI 1538149844
Payments from drug & device makers
Across 181 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$625
- AbbVie$393
- Lilly USA, LLC$211
- Sanofi-aventis U.S. LLC$205
- Novartis$177
- Astellas Pharma US Inc$158
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,00196%
- Gifts$1194%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 55 | $625 |
| AbbVie(2 entities) | 24 | $393 |
| Lilly USA, LLC | 13 | $211 |
| Sanofi-aventis U.S. LLC | 6 | $205 |
| Novartis | 7 | $177 |
| Astellas Pharma US Inc | 9 | $158 |
| Mannkind Corporation | 3 | $142 |
| Pfizer | 8 | $132 |
| Abbott | 6 | $123 |
| GSK | 6 | $119 |
| AstraZeneca | 8 | $117 |
| Merck | 6 | $97 |
| Dexcom, Inc. | 2 | $95 |
| Hologic Sales And Service, LLC | 1 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $63 |
| Biohaven Pharmaceuticals, Inc. | 3 | $57 |
| Philips North America LLC | 4 | $52 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Amgen | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $28 |
| Sun Pharmaceutical Industries Inc. | 1 | $27 |
| Johnson & Johnson | 1 | $20 |
| Medtronic | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
How this compares
$3,119 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 18 | $263 |
| Losartan Potassium | 22 | $256 |
| Levothyroxine Sodium | 13 | $137 |
| Rosuvastatin Calcium | 11 | $133 |
| Atorvastatin Calcium | 27 | $125 |
| Enalapril Maleate | 14 | $100 |
| Lisinopril | 11 | $86 |
| Metoprolol Succinate | 12 | $84 |
| Amlodipine Besylate | 12 | $58 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Pottstown
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.